New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3
Low-density lipoprotein cholesterol (LDL-C)-lowering therapy that increases LDL receptor expression in several ways robustly reduces the risk of atherosclerotic cardiovascular disease (CVD). However, a substantial risk of CVD still remains after intensive LDL-C reduction, which requires new treatmen...
সংরক্ষণ করুন:
| প্রধান লেখক: | , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
The Korean Society of Lipid and Atherosclerosis
2023-01-01
|
| মালা: | Journal of Lipid and Atherosclerosis |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2023.12.1.23&code=9992JLA&vmode=FULL |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|